(Bloomberg) -- Eurofins Scientific SE rejected allegations made by Carson Block’s Muddy Waters Research that caused its stock to plunge the most in two decades, saying it’s confident in the integrity of its accounts. Most Read from Bloomberg Nvidia’s 13% Stock Rout Has Traders Scouring Charts for Support BuzzFeed Struggles to Sell Owner of Hit YouTube Show ‘Hot Ones’ Jain Global Raises $5.3 Billion, Secures Cash From Abu Dhabi How Long Can High Rates Last? Bond Markets Say Maybe Forever Tech Hits Stocks as Nvidia Extends Selloff to 13%: Markets Wrap The company’s profit and revenue growth over the past two decades should back up its investment decisions, Eurofins said in a statement, dismissing the short seller’s report as “insidious allegations.” The stock recovered on Tuesday, rising more than 5% in Paris trading after Monday’s 16% decline. “Trading is likely to remain choppy in the near term,” Nupur Gupta, an equity analyst at AlphaValue, wrote in a note. The firm is keeping its positive stance on the stock given Eurofins’s “market leading position in niche-testing end markets.” The company defended its higher costs per employee, saying it uses highly skilled staff to test for the pharma industry. Luxembourg-based Eurofins also offers testing services to the makers of food and cosmetics, among others. Eurofins will work together with its auditors to prepare further analyses to refute the allegations, it said. “We have been and always will be committed to fair and clear disclosures,” said founder and Chief Executive Officer Gilles Martin. Muddy Waters on Monday disclosed a short position and cast doubt on Eurofins’s financial statements, saying the firm’s reports could contain “material overstatements of profits, cash balances, and other asset values.” The company responded that it’s confident in the integrity of its accounts, operational performance, internal controls and risk management. It’s not the first time that Luxembourg-based Eurofins has been targeted by a short seller. In 2019, ShadowFall criticized the company’s governance, accounting at subsidiaries and debt levels. Eurofins defended its governance practices and rejected ShadowFall’s criticism as inaccurate and unfounded. --With assistance from Blaise Robinson. Most Read from Bloomberg Businessweek How Jeff Yass Became One of the Most Influential Billionaires in the 2024 Election Corporate Women’s Gains Fall Victim to Anti-Woke Backlash Why BYD’s Wang Chuanfu Could Be China’s Version of Henry Ford How to Do a Four-Day Workweek That Actually Works Ilya Sutskever Has a New Plan for Safe Superintelligence ©2024 Bloomberg L.P.
Eurofins Rejects Muddy Waters Attack as Shares Edge Back Up
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...